Risdiplam is a chemical compound used as an active pharmaceutical ingredient in the manufacturing of oral medications for spinal muscular atrophy. It was the first oral medication approved by the US FDA for this condition.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Risdiplam?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Ravuconazole
pharmaceutical raw material
Tert-Butyl {(2S,3R)-4-[(4-aminobenzene-1-sulfonyl)(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl}carbamate
pharmaceutical raw material
Fenproporex hydrochloride
pharmaceutical raw material
Cabazitaxel
pharmaceutical raw material
Risdiplam metabolite M1
pharmaceutical raw material
Tert-Butyl 7-(2-(2,8-dimethylimidazo[1,2-b]pyridazin-6-yl)-4-oxo-4H-pyrido[1,2-a]pyrimidin-7-yl)-4,7-diazaspiro[2.5]octane-4-carboxylate
research compound
The international HS code for Risdiplam (CAS 1825352-65-5) is 2933.59.
2933.59
2933 59 95
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
7-(4,7-diazaspiro[2.5]octan-7-yl)-2-(2,8-dimethylimidazo[1,2-b]pyridazin-6-yl)pyrido[1,2-a]pyrimidin-4-one
ASKZRYGFUPSJPN-UHFFFAOYSA-N
CC1=CC(=NN2C1=NC(=C2)C)C3=CC(=O)N4C=C(C=CC4=N3)N5CCNC6(C5)CC6
Sourcing Risdiplam?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.